Edition:
United States

Alnylam Pharmaceuticals Inc (ALNY.O)

ALNY.O on Nasdaq

65.80USD
26 May 2017
Change (% chg)

$-3.70 (-5.32%)
Prev Close
$69.50
Open
$69.27
Day's High
$70.49
Day's Low
$65.50
Volume
1,356,852
Avg. Vol
1,029,951
52-wk High
$80.11
52-wk Low
$31.38

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -1.23 December 26 May 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 1 3 2
(2) OUTPERFORM 7 7 6 6
(3) HOLD 7 7 6 7
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.31 2.40 2.20 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-17 13 22.76 39.00 2.00 9.00
Quarter Ending Sep-17 13 21.58 37.00 2.00 9.00
Year Ending Dec-17 16 77.45 106.00 25.00 57.95
Year Ending Dec-18 15 147.33 274.70 46.18 159.89
Earnings (per share)
Quarter Ending Jun-17 13 -1.23 -1.03 -1.46 -1.39
Quarter Ending Sep-17 13 -1.33 -1.12 -1.70 -1.38
Year Ending Dec-17 15 -5.34 -4.63 -6.43 -5.36
Year Ending Dec-18 14 -4.99 -3.10 -6.20 -4.01

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-17 23.64 18.96 4.68 19.81
Quarter Ending Dec-16 10.95 17.45 6.50 59.40
Quarter Ending Sep-16 9.14 13.65 4.51 49.35
Quarter Ending Jun-16 8.09 8.71 0.62 7.64
Quarter Ending Mar-16 7.74 7.34 0.40 5.16
Earnings (per share)
Quarter Ending Mar-17 -1.26 -1.25 0.01 -0.73
Quarter Ending Dec-16 -1.34 -1.32 0.02 -1.73
Quarter Ending Sep-16 -1.14 -1.21 0.07 -6.35
Quarter Ending Jun-16 -1.24 -1.05 0.19 -15.38
Quarter Ending Mar-16 -1.05 -1.21 0.16 -15.13

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-17 22.76 22.76 21.47 20.83 9.00
Quarter Ending Sep-17 21.58 21.58 17.17 16.89 9.00
Year Ending Dec-17 77.45 77.45 73.71 75.96 57.95
Year Ending Dec-18 147.33 146.88 156.06 161.66 159.89
Earnings (per share)
Quarter Ending Jun-17 -1.23 -1.23 -1.25 -1.29 -1.39
Quarter Ending Sep-17 -1.33 -1.34 -1.38 -1.41 -1.38
Year Ending Dec-17 -5.34 -5.35 -5.16 -5.12 -5.36
Year Ending Dec-18 -4.99 -5.02 -4.42 -4.47 -4.01

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-17 0 0 5 1
Quarter Ending Sep-17 0 0 8 0
Year Ending Dec-17 0 0 11 3
Year Ending Dec-18 1 0 7 4
Earnings
Quarter Ending Jun-17 0 0 7 5
Quarter Ending Sep-17 1 0 8 3
Year Ending Dec-17 1 0 5 10
Year Ending Dec-18 2 0 5 9

More From Around the Web